Lessons from the European Regulation 1223 of 2009, on Cosmetics: Expectations Versus Reality

Springer Science and Business Media LLC - Tập 13 - Trang 21-35 - 2019
Ricardo Santana Cabello1, Piedad Gañán Rojo2, Robin Zuluaga3
1Grupo de Investigación Sobre Nuevos Materiales, Universidad Pontificia Bolivariana, Medellín, Colombia
2Facultad de Ingeniería Química, Universidad Pontificia Bolivariana, Medellín, Colombia
3Facultad de Ingeniería Agroindustrial, Universidad Pontificia Bolivariana, Medellín, Colombia

Tóm tắt

The aim of this paper is to conduct an analysis of the application of the specific rules of nanotechnology incorporated in Regulation No. 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products. It has been ten years since the European Commission had issued its proposal to start the co-decision procedure to create Regulation 1223 of 2009. Although it has been praised for noting the regulatory difference of nanomaterials over the rest of the chemicals, what has been the efficacy of the standard? It is concluded that despite what it meant, the regulation has encountered technical obstacles, thus rendering the objectives relating to nanotechnology that were proposed from the European Commission unfulfilled. This finding is inferred through legal dogmatic methodologies and the identification of nanomaterials that have not been expressly approved. Nevertheless, products incorporating nanomaterials still circulate in the European market. The precepts about nanotechnology in the regulation should be reviewed because technical inconsistencies should be avoided in future regulations or applicable regulations in contexts other than Europe. Such inconsistencies exist with respect to the high level of protection of human health that should be ensured and the provisions intended to protect consumer safety. For instance, the catalog of nanomaterials in circulation does not indicate the materials that have been approved or their toxicological profiles. To date, no comparison studies have been presented between the expectations and legislative objectives set as embodied in the regulation and debated in the European Parliament involving the actual efficacy of this regulation.

Tài liệu tham khảo

Miller G (2008) Contemplating the implications of a nanotechnology “revolution”. In: Fisher E, Selin C, Wetmore JM (eds) Presenting futures. The yearbook of nanotechnology in society, vol 1. Springer, Dordrecht, pp 215–225 Organisation for Economic Co-operation and Development (2013) Nanotechnology in the context of technology convergence. OECD, Paris European Commission (2016) Horizon 2020 Work Programme 2016–2017. 5.ii. Nanotechnologies, Advanced Materials, Biotechnology and Advanced Manufacturing and Processing. EC, Brussels Food and Drug Administration (2014) Guidance for industry “considering whether an FDA-regulated product involves the application of nanotechnology”. FDA, Washington, DC World Intellectual Property Organization (2015) Economic growth and breakthrough innovations: a case study of nanotechnology. WIPO, Geneva See: http://product.statnano.com/. Accessed 13 Feb 2019 Bowman DM (2017) More than a decade on: mapping today’s regulatory and policy landscapes following the publication of nanoscience and nanotechnologies: opportunities and uncertainties. NanoEthics 11(2):169–186. https://doi.org/10.1007/s11569-017-0281-x Lai RWS, Yeung KWY, Yung MMN, Djurišić AB, Giesy JP, Leung KMY (2017) Regulation of engineered nanomaterials: current challenges, insights and future directions. Environ Sci Pollut Res 25:1–18. https://doi.org/10.1007/s11356-017-9489-0 Food and Drug Administration (2014) Office of the Commissioner, FDA, guidance for industry: considering whether an FDA-regulated product involves the application of nanotechnology. FDA, Washington, DC Burden N, Aschberger K, Chaudhry Q (2017) The 3Rs as a framework to support a 21st century approach for nanosafety assessment. Nano Today 12:10–13. https://doi.org/10.1016/j.nantod.2016.06.007 Reimhult E (2017) Nanoparticle risks and identification in a world where small things do not survive. NanoEthics 11(3):283–290. https://doi.org/10.1007/s11569-017-0305-6 Maynard AD, Aitken RJ (2016) Safe handling of nanotechnology ten years on. Nat Nanotechnol 11:998–1000. https://doi.org/10.1038/nnano.2016.270 Bowman DM, Chaudhry Q, Gergely A (2015) Evidence-based regulation of food nanotechnologies: a perspective from the European Union and United States. In: Sabliov CM, Chen H, Yada RY (eds) Nanotechnology and functional foods: effective delivery of bioactive ingredients. Wiley, NJ, pp 358–374 Royal Society and Royal Academy of Engineering (2004) Nanoscience and nanotechnologies: opportunities and uncertainties. RS/RAEng, London Justo-Hanani R, Dayan T (2015) European risk governance of nanotechnology: explaining the emerging regulatory policy. Res Policy 44:1527–1536. https://doi.org/10.1016/j.respol.2015.05.001 Official Journal of the European Union (2009) Regulation (EC) 1223/2009 of the European Parliament and of the Council on cosmetic products (recast). 30 November 2009. EU, Brussels Future Markets (2012) Nanomaterials in the cosmetics and personal care. http://www.researchandmarkets.com/reports/2069662/nanomaterials_in_the_cosmetics_and_personal_care Council of the European Communities (1976) Council Directive on the approximation of the laws of the Member States relating to cosmetic products (No 76/768/EEC, 27 Jul, 1976). CEC, Brussels European Commission (2008) Proposal for a Regulation of the European Parliament and of the Council on cosmetic products (No COM (2008) 49 final, 05 Feb 2008). EC, Brussels European Commission (2008) Accompanying document to the communication from the Commission to the European Parliament, the Council and the European Economic and Social Committee (Commission Staff Working Paper No SEC (2008) 117, 05 Feb 2008). EC, Brussels European Commission (2008) Communication from the Commission to the European Parliament, the Council and the European Economic and Social Committee. Regulatory Aspects of Nanomaterials (No COM (2008) 366 final, 17 Jun 2008). EC, Brussels European Economic and Social Committee (2008) Opinion of the European Economic and Social Committee on the ‘Proposal for a Regulation of the European Parliament and of the Council on cosmetic products’ (No CESE (2008) 1193, 09 Jul 2008). EESC, Brussels European Parliament (2008) Report on the proposal for a regulation of the European Parliament and of the Council on cosmetic products (No A6 (2008) 484, 02 Dec 2008). EP, Brussels European Parliament (2009) Debate about cosmetic products (recast version, CRE 23/03/2009–15, 23 Mar 2009). EP, Strasbourg European Parliament Press Release (2009) MEPs approve new rules on safer cosmetics (24 Mar 2009). EP, Brussels European Commission (2016) Commission Regulation amending Annex VI to Regulation (EC) No 1223/2009 of the European Parliament and of the Council, on cosmetic products (C/2016/4325). EC, Brussels European Parliament (2008) A guide to how the European Parliament co-legislates under the ordinary legislative procedure, Brussels. EP European Commission (2012) Cosmetic products notification portal. Article 13 User Manual. EC, Brussels European Commission (2008) Commission decision setting up an advisory structure of scientific committees and experts in the field of consumer safety, public health and the environment and repealing (No 721/EC (2008)). EC, Brussels European Commission (2012) User manual for the notification of cosmetic products containing nanomaterial according to article 16. EC, Brussels European Commission (2017) Catalogue of nanomaterials used in cosmetic products placed on the EU market. Version 1 (31.12.2016). EC, Brussels Scientific Committee on Consumer Safety (2015) Second revision opinion on carbon black (nano-form) (no SCCS/1515/13). SCCS, Brussels European Commission (2016) Commission Regulation (EU) 2016/1143 amending Annex VI to Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products (13 July 2016). EC, Brussels Scientific Committee on Consumer Safety (2015) Second revision opinion on titanium dioxide (nano form) (no SCCS/1516/13). SCCS, Brussels European Commission (2014) Commission Regulation (EU) 2016/1143 amending Annexes III, V and VI to Regulation (EC) No 1223/2009 of the European Parliament and the Council on cosmetic products (08 Aug 2014). EC, Brussels Scientific Committee on Consumer Safety (2015) Second revision opinion on 1,3,5-triazine, 2,4,6-tris[1,1′-biphenyl]-4-yl (No SCCS/1429/11). SCCS, Brussels European Commission (2016) Commission Regulation (EU) 2016/621 amending Annex VI to Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products (21 April 2016). EC, Brussels Scientific Committee on Consumer Safety (2012) Second revision opinion on zinc oxide (nano form). (No SCCS/1489/12). SCCS, Brussels Scientific Committee on Consumer Safety (2013) Second revision opinion on zinc oxide (nano form). (No SCCS/1518/13). SCCS, Brussels Hansen S (2017) React now regarding nanomaterial regulation. Nat Nanotechnol 12:714–716. https://doi.org/10.1038/nnano.2017.163 European Commission (2012) Communication from the Commission to the European Parliament, the Council and the European Economic and Social Committee. Second regulatory review on nanomaterials (no COM(2012) 572, 3 Oct 2012). EC, Brussels JRC (2010) Considerations on a definition of nanomaterial for regulatory purposes. JRC, Brussels